CervoMed, Inc. (CRVO)
1.42
-0.03
(-2.07%)
USD |
NASDAQ |
Nov 06, 10:07
CervoMed Price to Book Value : 0.8365 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 0.8542 |
| November 04, 2026 | 0.919 |
| November 03, 2026 | 0.9131 |
| November 02, 2026 | 0.9661 |
| October 30, 2026 | 0.9426 |
| October 29, 2026 | 1.031 |
| October 28, 2026 | 1.302 |
| October 27, 2026 | 1.308 |
| October 26, 2026 | 1.320 |
| October 23, 2026 | 1.361 |
| October 22, 2026 | 1.320 |
| October 21, 2026 | 1.378 |
| October 20, 2026 | 1.349 |
| October 19, 2026 | 1.361 |
| October 16, 2026 | 1.320 |
| October 15, 2026 | 1.326 |
| October 14, 2026 | 1.349 |
| October 13, 2026 | 1.337 |
| October 12, 2026 | 1.479 |
| October 09, 2026 | 1.897 |
| October 08, 2026 | 1.932 |
| October 07, 2026 | 1.873 |
| October 06, 2026 | 1.968 |
| October 05, 2026 | 1.95 |
| October 02, 2026 | 1.779 |
| Date | Value |
|---|---|
| October 01, 2026 | 1.726 |
| September 30, 2026 | 1.750 |
| September 29, 2026 | 1.697 |
| September 28, 2026 | 1.573 |
| September 25, 2026 | 1.496 |
| September 24, 2026 | 1.485 |
| September 23, 2026 | 1.479 |
| September 22, 2026 | 1.490 |
| September 21, 2026 | 1.420 |
| September 18, 2026 | 1.432 |
| September 17, 2026 | 1.502 |
| September 16, 2026 | 1.437 |
| September 15, 2026 | 1.443 |
| September 14, 2026 | 1.490 |
| September 11, 2026 | 1.514 |
| September 10, 2026 | 1.461 |
| September 09, 2026 | 1.479 |
| September 08, 2026 | 1.490 |
| September 04, 2026 | 1.508 |
| September 03, 2026 | 1.496 |
| September 02, 2026 | 1.555 |
| September 01, 2026 | 1.514 |
| August 31, 2026 | 1.549 |
| August 28, 2026 | 1.532 |
| August 27, 2026 | 1.555 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.757 |
| Alnylam Pharmaceuticals, Inc. | 5.846 |
| Anika Therapeutics, Inc. | 1.638 |
| Savara, Inc. | 6.563 |
| Vericel Corp. | 7.116 |
Price to Book Value Related Metrics
| PS Ratio | 40.73 |
| PEG Ratio | -0.0191 |
| Price | 1.42 |
| Earnings Yield | -226.1% |
| Market Cap | 19.21M |
| PEGY Ratio | -0.0191 |